HomeProfessor Product PortalCravatt Group – Professor Product Portal

Cravatt Group – Professor Product Portal

Ben Cravatt

Professor Ben Cravatt

The aim of the Cravatt research group is to understand the roles that mammalian enzymes play in physiological and pathological processes and to use this knowledge to identify novel therapeutic targets for the treatment of human disease. To achieve these goals, they develop and apply new technologies that bridge the fields of chemistry and biology, ascribing to the philosophy that the most significant biomedical problems require creative multidisciplinary approaches for their solution. The group's technological innovations address fundamental challenges in systems biology that are beyond the scope of contemporary methods.

For instance, enzymes are tightly regulated by post-translational events in vivo, meaning that their activity may not correlate with expression as measured by standard genomic and proteomic approaches. Considering that it is an enzyme's activity, rather than abundance that ultimately dictates its role in cell physiology and pathology, the Cravatt group has introduced a set of proteomic technologies that directly measures this parameter. These activity-based protein profiling (ABPP) methods exploit the power of chemistry to engender new tools and assays for the global analysis of enzyme activities. The enzyme activity profiles generated by ABPP constitute unique molecular portraits of cells and tissues that illuminate how metabolic and signaling networks are regulated in vivo. Additionally, by evaluating enzymes based on functional properties rather than mere abundance, ABPP acquires high-content proteomic information that is enriched in novel markers and targets for the diagnosis and treatment of human disease.

Cravatt Group Website

Recent papers from the Cravatt Group

Hsu K, Tsuboi K, Adibekian A, Pugh H, Masuda K, Cravatt BF. 2012. DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses. Nat Chem Biol. 8(12):999-1007.
Hsu K, Tsuboi K, Chang JW, Whitby LR, Speers AE, Pugh H, Cravatt BF. 2013. Discovery and Optimization of Piperidyl-1,2,3-Triazole Ureas as Potent, Selective, and in Vivo-Active Inhibitors of α/β-Hydrolase Domain Containing 6 (ABHD6). J. Med. Chem.. 56(21):8270-8279.
Products available from the Cravatt Group


  • Organic Synthetic Chemistry
  • Chemical Biology

Professor Product Portal Index